Evidence map›Paper›PMID 33414512›Full record

ArticleBone marrow transplantation2021

Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.

Xueyan Sun, Yan Su, Xiao Liu, Yuanyuan Zhang, Yun He, Wei Han, Qi Chen, Huan Chen, Yu Wang, Yifei Cheng and 13 more

Abstract read
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Xueyan Sun *Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yan Su *Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Xiao Liu *Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yuanyuan ZhangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yun HePeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Wei HanPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Qi ChenPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Huan ChenPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yu WangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yifei ChengPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Fengqi LiuPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Fengrong WangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yao ChenPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Gaochao ZhangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Xiaodong MoPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Haixia FuPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Yuhong ChenPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Jingzhi WangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Xiaolu ZhuPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Lanping XuPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Kaiyan LiuPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Xiaojun HuangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Xiaohui ZhangPeking University People's Hospital, Peking University Institute of Haematology, Beijing, China. zhangxh100@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal bleeding (GIB) accounts for a significant proportion of life-threatening bleeding cases occurring after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, data on GIB after haploidentical HSCT (haplo-HSCT) are not available. A total of 3180 patients received haplo-HSCT at Peking University People's Hospital from January 2015 to November 2019, and GIB occurred in 188 of these patients (incidence of 5.9%). Platelet counts <30 × 10

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationGastrointestinal HemorrhageHumansIncidenceRetrospective Studies

Identifiers

PMID33414512
PMCPMC8189916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.